More information about location
AI-powered medical R&D
Open for applications
More information about location
21-100 employees
To tackle inefficiencies in healthcare with disease specific solutions, improving outcomes for patients.
The advancement of AI means that medical data can be analysed to predict health risks, enabling proactive care which reduces costs and improves outcomes. Ikerian, formerly RetinAI Medical, is a Swiss digital healthcare firm dedicated to enabling faster and better healthcare decisions.
The company leverages AI to streamline medical image and data management, standardising and analysing multimodal healthcare data. It serves a range of medical sectors, including rare diseases, and has made noteworthy collaborations with industry leaders and major pharma players. In 2024, it made moves into a new market, debuting the discovery platform for ophthalmologists and optometrists.
In 2025, Ikerian was acquired by eyewear and lens multinational EssilorLuxottica, which will utilise its software for its products. Ultimately, the company's vision is to democratise accessible healthcare, leveraging data to address systemic and chronic diseases.

Steph
Company Specialist at Welcome to the Jungle
Mattenhof, Bern, BE
Carlos Ciller
(Co-Founder & CEO)Also works as a Startup Trainer and Coach for Venturelab. Previously worked for the Innovation Forum as Director of Global Business Development.
Stefanos Apostolopoulos
(Co-Founder & CTO)Also works as Project Lead at The Open Toolkit Library. Prior to this, was a Doctoral Assistant for the ARTORG Center for Biomedical Engineering Research.
Share this job
View 2 more jobs at Ikerian
